Labron Healthcare Profile
Key Indicators
- Authorised Capital ₹ 2.50 Cr
as on 17-12-2024
- Paid Up Capital ₹ 2.25 Cr
as on 17-12-2024
- Company Age 13 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 8.74 Cr
as on 17-12-2024
- Revenue 147.47%
(FY 2022)
- Profit -8.37%
(FY 2022)
- Ebitda 120.42%
(FY 2022)
- Net Worth -39.80%
(FY 2022)
- Total Assets 8.58%
(FY 2022)
About Labron Healthcare
The Corporate was formerly known as Autoelec Polymers Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 Cr and a paid-up capital of Rs 2.25 Cr.
The company currently has active open charges totaling ₹8.74 Cr.
Devchand Patel, Ankit Poddar, Sanjaykumar Patel, and One other member serve as directors at the Company.
- CIN/LLPIN
U24100GJ2011PTC065422
- Company No.
065422
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 May 2011
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Gandhi Nagar, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Labron Healthcare?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Agrawal Niranjan  | Director | 01-Dec-2018 | Current |
| Devchand Patel | Director | 04-Feb-2019 | Current |
| Ankit Poddar | Director | 25-May-2017 | Current |
| Sanjaykumar Patel | Director | 04-Feb-2019 | Current |
Financial Performance of Labron Healthcare.
Labron Healthcare Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 147.47% increase. The company also saw a slight decrease in profitability, with a 8.37% decrease in profit. The company's net worth observed a substantial decline by a decrease of 39.8%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Labron Healthcare?
In 2021, Labron Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Skyfield Minerals (India) LlpActive 8 years 4 monthsDevchand Patel and Sanjaykumar Patel are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 24 Dec 2019 | ₹0.46 M | Open |
Others Creation Date: 13 Sep 2019 | ₹4.35 Cr | Open |
Others Creation Date: 11 Sep 2019 | ₹4.35 Cr | Open |
How Many Employees Work at Labron Healthcare?
Labron Healthcare has a workforce of 7 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Labron Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Labron Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
